Abstract
The serotonin transporter polymorphism has been implicated in obsessive-compulsive disorder (OCD). However, molecular genetic association studies have yielded inconsistent results. Variation may be due to lack of OCD subtype classification. The goal of this systematic review is to investigate the association of the S-allele of the serotonin transporter polymorphism with OCD and OCD subtypes. A total of 69 studies were initially found through a systematic search of the literature but only 13 with sufficient information to compute odds ratios were suitable for review. A total of 1991 participants with OCD and their 5-HTTLPR allele status were examined. The primary outcome measures were allele frequency and OCD diagnosis. A full meta-analysis was completed comparing the L- and S-alleles using a random effects model in RevMan 5.2.1. Further, a secondary meta-analysis stratified by sex and late-onset was conducted for S- versus L-allele frequency. In the primary meta-analysis, OCD was not associated with the S-allele of the 5-HTTLPR polymorphism (Z = 0.07, p = 0.94). Moreover, late-onset OCD was not associated with the S-allele (Z = 1.45, p = 0.15). However, when stratified by sex, there is an emerging sex-specific relationship. There was a trending association between the S-allele and OCD status in females (Z = 1.62, p = 0.10) but not in males (Z = 0.69, p = 0.49). The findings provide further support for the need of subtype classification of this heterogeneous disorder. Future studies should clearly examine sex differences and OCD age-of-onset. In particular, emphasis should be placed on the effect of female reproductive milestones on OCD onset and symptom exacerbation.
Similar content being viewed by others
References
Abramowitz JS, Taylor S, McKay D (2009) Obsessive-compulsive disorder. Lancet 374(9688):491–499
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing, Arlington
Atmaca M, Onalan E, Yildirim H, Yuce H, Koc M, Korkmaz S, Mermi O (2011) Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder. J Anxiety Disord 25(5):680–685
Baca-García E, Salgado BR, Segal HD, Lorenzo CV, Acosta MN, Romero MA et al (2005) A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism. Prog Neuro-Psychopharmacol Biol Psychiatry 29(5):713–717
Barr CS, Newman TK, Schwandt M, Shannon C, Dvoskin RL, Lindell SG et al (2004) Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc Natl Acad Sci U S A 101(33):12358–12363
Bengel D, Greenberg BD, Corá-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL (1999) Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4(5):463–466
Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V et al (2008) Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. Am J Med Genet B Neuropsychiatr Genet 147B(6):850–858
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2011) Introduction to meta-analysis. John Wiley & Sons, Chichester
Camarena B, Rinetti G, Cruz C (2001) Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. Int J Neuropsychopharmacol. doi:10.1017/S1461145701002516
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389
Caspi A, Vishne T, Sasson Y, Gross R, Livne A, Zohar J (2008) Relationship between childhood sexual abuse and obsessive-compulsive disorder: case control study. Isr J Psychiatry Relat Sci 45(3):177–182
Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE (2010) Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167(5):509–527
Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE et al (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8(4):387–391
Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L (2002) Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet B Neuropsychiatr Genet 114(3):347–353
Chabane N, Millet B, Delorme R, Lichtermann D, Mathieu F, Laplanche JL et al (2004) Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci Lett 363(2):154–156
Chiao JY, Blizinsky KD (2010) Culture-gene coevolution of individualism-collectivism and the serotonin transporter gene. Proc R Soc B Biol Sci 277(1681):529–537
de Mathis MA, de Alvarenga P, Funaro G, Torresan RC, Moraes I, Torres AR et al (2011) Gender differences in obsessive-compulsive disorder: a literature review. Rev Bras Psiquiatr (São Paulo, Brazil : 1999) 33(4):390–399
Denys D, Vannieuwerburgh F, Deforce D, Westenberg H (2006) Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord 91(1):39–44
Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L (2002) Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J 2(3):176–181
Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Psychiatry 295(11):1288–1299
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 315(7109):629–634
Eisenberg DTA, Hayes MG (2010) Testing the null hypothesis: comments on “Culture-gene coevolution of individualism-collectivism and the serotonin transporter gene”. Proc R Soc B Biol Sci 278(1704):329–332
Field AP, Gillett R (2010) How to do a meta-analysis. Br J Math Stat Psychol 63(Pt 3):665–694
Forray A, Focseneanu M, Pittman B, McDougle CJ, Epperson CN (2010) Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry 71(8):1061–1068
Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N et al (2000) Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 10(3):205–209
Gelernter J, Kranzler H, Cubells JF (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet 101(2):243–246
Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297(5580):400–403
Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR (2005) A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 62(2):146–152
Hesse S, Stengler K, Regenthal R, Patt M, Becker G-A, Franke A et al (2011) The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 14(05):606–617
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed) 327(7414):557–560
Hollander E, Kim S, Braun A, Simeon D, Zohar J (2009) Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Res 170(1):3–6
Hu X-Z, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78(5):815–826
Janowitz D, Grabe HJ, Ruhrmann S, Ettelt S, Buhtz F, Hochrein A et al (2009) Early onset of obsessive-compulsive disorder and associated comorbidity. Depress Anxiety 26(11):1012–1017
Karadaĝ F, Oguzhanoglu NK, Özdel O, Ateşci FÇ, Amuk T (2006) OCD symptoms in a sample of Turkish patients: a phenomenological picture. Depress Anxiety 23(3):145–152
Kim SJ, Lee HS, Kim C-H (2005) Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology 52(4):176–182
Kinnear CJ, Niehaus DJH, Moolman-Smook JC, Toit du PL, van Kradenberg J, Weyers JB et al (2000) Obsessive-compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int J Neuropsychopharmacol 3(4):327–331
Kontopantelis E, Springate DA, Reeves D (2013) A re-analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta-analyses. PLoS ONE 8(7):e69930
Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Jaurrieta N et al (2008) Gender differences in obsessive-compulsive symptom dimensions. Depress Anxiety 25(10):832–838
Labad J, Alonso P, Segalas C, Real E, Jimenez S, Bueno B et al (2009) Distinct correlates of hoarding and cleaning symptom dimensions in relation to onset of obsessive-compulsive disorder at menarche or the perinatal period. Arch Women’s Ment Health 13(1):75–81
Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531
Lin P-Y (2007) Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 31(3):683–689
Liu S-G, Zhang X-H, Yin Y-Y, Wang M-J, Che F-Y, Ma X (2011) An association analysis between 5-HTTLPR polymorphism and obsessive-compulsive disorder, Tourette syndrome in a Chinese Han population. CNS Neurosci Ther 17(6):793–795
Lochner C, Stein DJ (2006) Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder? Prog Neuro-Psychopharmacol Biol Psychiatry 30(3):353–361
Lochner C, Hemmings SMJ, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA et al (2004) Gender in obsessive-compulsive disorder: clinical and genetic findings. Eur Neuropsychopharmacol 14(2):105–113
Lochner C, Hemmings SMJ, Kinnear CJ, Niehaus DJH, Nel DG, Corfield VA et al (2005) Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry 46(1):14–19
Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M (2011) Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. J Clin Psychiatry 72(11):e1563–e1569
Mathews CA, Kaur N, Stein MB (2008) Childhood trauma and obsessive-compulsive symptoms. Depress Anxiety 25(9):742–751
Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y et al (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: A [11C]DASB PET study. NeuroImage 49(1):121–126
Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H (2004) Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav 3(2):75–79
Nakamura M, Ueno S, Sano A, Tanabe H (2000) The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5(1):32–38
Nicolini H, Arnold P, Nestadt G, Lanzagorta N, Kennedy JL (2009) Overview of genetics and obsessive-compulsive disorder. Psychiatry Res 170(1):7–14
Pampaloni I, Sivakumaran T, Hawley CJ, Allaq Al A, Farrow J, Nelson S, Fineberg NA (2010) High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey. J Psychopharmacol (Oxford, England) 24(10):1439–1445
Pato MT, Pato CN, Pauls DL (2002) Recent findings in the genetics of OCD. J Clin Psychiatry 63(Suppl 6):30–33
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8(6):828–834
Real E, Labad J, Alonso P, Segalas C, Jiménez-Murcia S, Bueno B et al (2011) Stressful life events at onset of obsessive-compulsive disorder are associated with a distinct clinical pattern. Depress Anxiety 28(5):367–376
Risch N, Herrell R, Lehner T, Liang K-Y, Eaves L, Hoh J et al (2009) Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. JAMA Psychiatry 301(23):2462–2471
Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44(9):839–850
Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2008) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15(1):53–63
Russell EJ, Fawcett JM, Mazmanian D (2013) Risk of obsessive-compulsive disorder in pregnant and postpartum women: a meta-analysis. J Clin Psychiatry 74(4):377–385
Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Bascaran M-T, Martinez-Barrondo S et al (2008) Association study between obsessive-compulsive disorder and serotonergic candidate genes. Prog Neuro-Psychopharmacol Biol Psychiatry 32(3):765–770
Schinka JA, Busch RM, Robichaux-Keene N (2004) A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9(2):197–202
Schmidt FL, Oh I-S, Hayes TL (2009) Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol 62(Pt 1):97–128
Smits KM, Smits LJM, Peeters FPML, Schouten JSAG, Janssen RGJH, Smeets HJM et al (2008) The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients. Psychiatr Genet 18(4):184–190
Taylor S (2011) Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev 31(7):1083–1100
Taylor S (2012a) Endophenotypes of obsessive-compulsive disorder: current status and future directions. J Obsessive-Compulsive Relat Disord 1(4):258–262
Taylor S (2012b) Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies. Mol Psychiatry 18(7):799–805
Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C (2007) Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care 30(4):854–860
Tibrewal P, Kumar K, Subhashree SGB, Purushottam M, Thennarasu K, Reddy JYC, Jain S (2010) Association of serotonin transporter gene polymorphisms with obsessive-compulsive disorder (OCD) in a south Indian population. Indian J Med Res 132:690–695
Torres AR, Lima MCP (2005) Epidemiology of obsessive-compulsive disorder: a review. Rev Bras Psiquiatr (São Paulo, Brazil : 1999) 27(3):237–242
Uguz F, Akman C, Kaya N, Cilli AS (2007) Postpartum-onset obsessive-compulsive disorder: incidence, clinical features, and related factors. J Clin Psychiatry 68(1):132–138
van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P (2011) Early-onset versus late-onset Alzheimer’s disease: the case of the missing APOE ɛ4 allele. Lancet Neurol 10(3):280–288
van IJzendoorn MH, Belsky J, Bakermans-Kranenburg MJ (2012) Serotonin transporter genotype 5HTTLPR as a marker of differential susceptibility? A meta-analysis of child and adolescent gene-by-environment studies. Trans Psychiatry 2:e147
Wendland JR, Kruse MR, Cromer KC, Murphy DL (2007) A large case–control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology 32(12):2543–2551
Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA et al (2011) Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Philadelphia, Pa) 4(1):23–33
Zalsman G, Huang Y-Y, Oquendo MA, Burke AK, Hu X-Z, Brent DA et al (2006) Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163(9):1588–1593
Acknowledgments
This research was supported in part by an educational grant from the Weisz Family Foundation. The funders had no role in the study design; collection, management, analysis, and interpretation of the data or in the preparation, review, and approval of the manuscript. We would like to thank Jean Maragno for her assistance with formulating the search strategy and Tina Li for her editorial assistance with the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mak, L., Streiner, D.L. & Steiner, M. Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis. Arch Womens Ment Health 18, 435–445 (2015). https://doi.org/10.1007/s00737-015-0526-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-015-0526-z